Autonomous Improvement in the Catalytic Activity of KVO_3/SiC for Soot Oxidation under Practical Gaseous Conditions
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-04-05
著者
-
Ogata Atsushi
Department Of Respiratory Medicine Allergy And Rheumatic Disease Osaka University Graduate School Of
-
Ogata Atsushi
The Second Department Of Internal Edicine Hyogo College Of Medicine
-
Ogata A
Atmospheric Environmental Protection Department National Institute For Resources And Environment
-
Ogata Atsushi
Atmospheric Environmental Protection Department National Institute For Resources And Environment
-
ZHAO Zhen
Catalysis Research Laboratory, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences
-
OBUCHI Akira
Atmospheric Environmental Protection Department, National Institute for Resources and Environment
-
UCHISAWA Junko
Atmospheric Environmental Protection Department, National Institute for Resources and Environment
-
KUSHIYAMA Satoshi
Atmospheric Environmental Protection Department, National Institute for Resources and Environment
-
Zhao Z
Univ. Sci. And Technol. China Anhui Chn
-
Obuchi Akira
National Institute Of Advanced Industrial Science And Technology (aist) Research Center For New Fuel
-
Uchisawa Junko
National Institute Of Advanced Industrial Science And Technology (aist) Research Center For New Fuel
-
Kushiyama Satoshi
Atmospheric Environmental Protection Department National Institute For Resources And Environment
-
Ogata Atsushi
Department Of Respiratory Medicine Allergy And Rheumatic Diseases Osaka University Graduate School O
関連論文
- Effects of Vanadyl Structure and Cs Addition on the Partial Oxidation of Ethane over V/SiO2 (第84回触媒討論会B講演予稿)
- Simulation on Soot Oxidation with NO2 and O2 in a Diesel Particulate Filter
- Increased serum interleukin-18 in a patient with systemic lupus erythematosus and T-cell large granular lymphocytic leukemia
- Autonomous Improvement in the Catalytic Activity of KVO_3/SiC for Soot Oxidation under Practical Gaseous Conditions
- Photoactivation of Methane on Metal Ion-Supported Silica Gel
- Catalytic Decomposition of N_2O over Rhodium-Loaded Metal Oxides
- An FTIR Study of the Species Adsorbed on a Rh/Al_2O_3 Catalyst in the Selective Reduction of NO by Propylene
- Levels of vascular endothelial growth factor and hepatocyte growth factor in sera of patients with rheumatic diseases
- Chemotherapy did not enhance the anti-osteolytic effects of bisphosphonate in multiple myeloma bone disease
- Successful Treatment of a Patient with Febrile, Lobular Panniculitis (Weber-Christian Disease) with Oral Cyclosporin A: Implications for Pathogenesis and Therapy
- Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway
- Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar Pollinosis
- Flavonoids and Related Compounds as Anti-Allergic Substances
- Clinical significance of interleukin-6 gene expression in the bone marrow of patients with multiple myeloma
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- Control of Adsorption by Microwave Irradiation
- Highly Selective NH_3 Formation in a NO-CO-H_2O Reaction over Pt/TiO_2
- Enhancement of Activity of Ir Catalysts for the Selective Catalytic Reduction of NO by CO
- Nitrogen-containing Compounds as a Reductant for the Selective Catalytic Reduction of NO
- Catalytic Hydrolysis of HCN over H-Ferrierite
- Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens
- Increased Hydrophobicity of Carboxymethyl Starch Film by Conjugation with Zein(Food & Nutrition Science)
- Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis
- Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
- Evidence of Local Heating of Catalyst during Soot Oxidation
- A case of Behcet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab